BetterLife Pharma Inc Cash Flow-to-Debt Ratio
BetterLife Pharma Inc cash flow-to-debt ratio. BetterLife Pharma Inc (NPAU) has a Cash Flow-to-Debt Ratio of -0.03x as of July 2025, meaning its operating cash flow of €-172.31K could theoretically repay 0% of its total liabilities (€6.04 Million) in one year. Check NPAU cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of BetterLife Pharma Inc (2017–2025)
Cash flow-to-debt ratio of BetterLife Pharma Inc from 2017 to 2025. Historical debt coverage capacity for BetterLife Pharma Inc across 9 annual periods. Also explore net asset growth rate of BetterLife Pharma Inc to track the company's year-over-year net asset growth rate.
BetterLife Pharma Inc Cash Flow-to-Debt Ratio by Year (2017–2025)
BetterLife Pharma Inc cash flow-to-debt ratio by year from 2017 to 2025. Year-by-year debt coverage analysis for BetterLife Pharma Inc. For the full cash flow conversion analysis, see NPAU cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.27x | €-2.02 Million | €7.59 Million | ▲ +13.6% |
| 2024 | -0.31x | €-2.47 Million | €8.02 Million | ▼ -56.0% |
| 2023 | -0.20x | €-1.50 Million | €7.61 Million | ▲ +91.1% |
| 2022 | -2.22x | €-11.20 Million | €5.04 Million | ▼ -84.5% |
| 2021 | -1.20x | €-7.16 Million | €5.95 Million | ▲ +14.5% |
| 2020 | -1.41x | €-7.88 Million | €5.59 Million | ▼ -52.2% |
| 2019 | -0.93x | €-4.71 Million | €5.09 Million | ▲ +12.7% |
| 2018 | -1.06x | €-561.52K | €529.51K | ▼ -521.3% |
| 2017 | -0.17x | €-359.45K | €2.11 Million | — |